These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10572962)

  • 21. In vivo applications of PEG liposomes: unexpected observations.
    Laverman P; Boerman OC; Oyen WJG ; Corstens FHM ; Storm G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(6):551-66. PubMed ID: 11789675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes.
    Moghimi SM; Hawley AE; Christy NM; Gray T; Illum L; Davis SS
    FEBS Lett; 1994 May; 344(1):25-30. PubMed ID: 8181558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery.
    Terentyuk GS; Maslyakova GN; Suleymanova LV; Khlebtsov BN; Kogan BY; Akchurin GG; Shantrocha AV; Maksimova IL; Khlebtsov NG; Tuchin VV
    J Biophotonics; 2009 May; 2(5):292-302. PubMed ID: 19434616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humoral-mediated recognition of 'phagocyte-resistant' beads by lymph node macrophages of poloxamine-treated rats.
    Moghimi SM
    Clin Sci (Lond); 1998 Sep; 95(3):389-91. PubMed ID: 9890787
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.
    Lode J; Fichtner I; Kreuter J; Berndt A; Diederichs JE; Reszka R
    Pharm Res; 2001 Nov; 18(11):1613-9. PubMed ID: 11758771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A noticeable phenomenon: thiol terminal PEG enhances the immunogenicity of PEGylated emulsions injected intravenously or subcutaneously into rats.
    Wang C; Cheng X; Sui Y; Luo X; Jiang G; Wang Y; Huang Z; She Z; Deng Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):744-51. PubMed ID: 24129310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908.
    Illum L; Davis SS; Müller RH; Mak E; West P
    Life Sci; 1987 Jan; 40(4):367-74. PubMed ID: 3807638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
    Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
    Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
    J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.
    Carrstensen H; Müller RH; Müller BW
    Clin Nutr; 1992 Oct; 11(5):289-97. PubMed ID: 16840011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermally gelling poloxamine Synperonic T908 solution as a vehicle for rectal drug delivery.
    Miyazaki S; Oda M; Takada M; Attwood D
    Biol Pharm Bull; 1995 Aug; 18(8):1151-3. PubMed ID: 8535415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
    Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G
    J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338).
    Illum L; Davis SS
    FEBS Lett; 1984 Feb; 167(1):79-82. PubMed ID: 6698206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A frustrating problem: accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats.
    Zhao Y; Wang C; Wang L; Yang Q; Tang W; She Z; Deng Y
    Eur J Pharm Biopharm; 2012 Aug; 81(3):506-13. PubMed ID: 22580209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers.
    Moghimi SM
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):131-9. PubMed ID: 12063176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative.
    Basile L; Passirani C; Huynh NT; Béjaud J; Benoit JP; Puglisi G; Pignatello R
    Int J Pharm; 2012 Apr; 426(1-2):231-238. PubMed ID: 22306040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro characterisation and biodistribution of some non-ionic surfactant coated liposomes in the rabbit.
    Khattab MA; Farr SJ; Taylor G; Kellaway IW
    J Drug Target; 1995; 3(1):39-49. PubMed ID: 7655819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
    Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
    J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.